These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3529961

  • 1. Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism.
    Travis PS, Cushner HM.
    Am J Med Sci; 1986 Oct; 292(4):235-40. PubMed ID: 3529961
    [Abstract] [Full Text] [Related]

  • 2. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
    Schambelan M, Sebastian A, Rector FC.
    Kidney Int; 1981 May; 19(5):716-27. PubMed ID: 7026872
    [Abstract] [Full Text] [Related]

  • 3. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H, Paillard M, Prigent A, Leviel F, Bichara M, Gardin JP, Idatte JM.
    Am J Nephrol; 1986 May; 6(4):253-62. PubMed ID: 3777034
    [Abstract] [Full Text] [Related]

  • 4. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
    Ehrlich EN, Lindheimer MD.
    J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
    [Abstract] [Full Text] [Related]

  • 5. Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism.
    Szylman P, Better OS, Chaimowitz C, Rosler A.
    N Engl J Med; 1976 Feb 12; 294(7):361-5. PubMed ID: 1674
    [Abstract] [Full Text] [Related]

  • 6. Familiar hyperkalaemic acidosis.
    Licht JH, Amundson D, Hsueh WA, Lombardo JV.
    Q J Med; 1985 Feb 12; 54(214):161-76. PubMed ID: 3885297
    [Abstract] [Full Text] [Related]

  • 7. Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.
    Batlle D, Arruda J.
    Adv Chronic Kidney Dis; 2018 Jul 12; 25(4):321-333. PubMed ID: 30139459
    [Abstract] [Full Text] [Related]

  • 8. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
    Gordon RD.
    Hypertension; 1986 Feb 12; 8(2):93-102. PubMed ID: 3002982
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P.
    Schweiz Med Wochenschr; 1982 Dec 04; 112(49):1764-74. PubMed ID: 6758113
    [Abstract] [Full Text] [Related]

  • 11. The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
    Klemm SA, Gordon RD, Tunny TJ, Thompson RE.
    Clin Invest Med; 1991 Dec 04; 14(6):551-8. PubMed ID: 1838973
    [Abstract] [Full Text] [Related]

  • 12. Early childhood hyperkalemia: variety of pseudohypoaldosteronism.
    Claris Appiani A, Marra G, Tirelli SA, Goj V, Romeo L, Cavanna G, Assael BM.
    Acta Paediatr Scand; 1986 Nov 04; 75(6):970-4. PubMed ID: 3551490
    [Abstract] [Full Text] [Related]

  • 13. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
    Mayan H, Vered I, Mouallem M, Tzadok-Witkon M, Pauzner R, Farfel Z.
    J Clin Endocrinol Metab; 2002 Jul 04; 87(7):3248-54. PubMed ID: 12107233
    [Abstract] [Full Text] [Related]

  • 14. Metabolic Acidosis, Hyperkalemia, and Renal Unresponsiveness to Aldosterone Syndrome: Response to Treatment with Low-Potassium Diet.
    Mehandru SK, Haroon A, Masud A, Shah J, Kaur S, Masud A, Hossain A, Asif A, Vachharajani TJ.
    Saudi J Kidney Dis Transpl; 2020 Jul 04; 31(5):1134-1139. PubMed ID: 33229781
    [Abstract] [Full Text] [Related]

  • 15. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL, Waeber B, Suc JM, Brunner HR, Tran-Van T, Durand D, Praddaude F.
    Arch Mal Coeur Vaiss; 1988 Jun 04; 81 Spec No():193-7. PubMed ID: 2973296
    [Abstract] [Full Text] [Related]

  • 16. Type II pseudohypoaldosteronism. Report of a case and review of the literature.
    Muhammad S, Mamish ZM, Tucci JR.
    J Endocrinol Invest; 1994 Jun 04; 17(6):453-7. PubMed ID: 7930391
    [Abstract] [Full Text] [Related]

  • 17. Treatment of mineralocorticoid-resistant renal hyperkalemia with hypertension (type II pseudohypoaldosteronism).
    Wayne VS, Stockigt JR, Jennings GL.
    Aust N Z J Med; 1986 Apr 04; 16(2):221-3. PubMed ID: 3463275
    [Abstract] [Full Text] [Related]

  • 18. Single administration of captopril and combined use with beta-blocker and/or thiazide diuretic in the treatment of essential hypertension.
    Yoneda S, Kako T, Koketsu M, Hayano J, Asakawa T, Fujinami T, Kato T.
    Angiology; 1991 Nov 04; 42(11):914-23. PubMed ID: 1683186
    [Abstract] [Full Text] [Related]

  • 19. Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone.
    Arruda JA, Batlle DC, Sehy JT, Roseman MK, Baronowski RL, Kurtzman NA.
    Am J Nephrol; 1981 Nov 04; 1(3-4):160-7. PubMed ID: 6758577
    [Abstract] [Full Text] [Related]

  • 20. [Primary hypoaldosteronism and secondary pseudo-hypoaldosteronism].
    Klaus D, Lederle RM, Vecsei P.
    Klin Wochenschr; 1984 Aug 16; 62(16):753-8. PubMed ID: 6090761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.